CCCC C4 Therapeutics, Inc.
C4 Therapeutics, Inc. (CCCC) Institutional Ownership
What the institutions did with CCCC last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.
Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.
Sign in or subscribeLargest holders
| Manager | Shares | % of reported |
|---|---|---|
| MORGAN STANLEY | 8.9M | 7.5% |
| RA CAPITAL MANAGEMENT, L.P. | 8.0M | 6.8% |
| BlackRock, Inc. | 7.9M | 6.7% |
| Lynx1 Capital Management LP | 7.3M | 6.2% |
| Squadron Capital Management LLC | 7.2M | 6.1% |
| Bain Capital Life Sciences Investors, LLC | 7.2M | 6.1% |
| JPMORGAN CHASE & CO | 4.7M | 4.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.4M | 3.8% |
| CITADEL ADVISORS LLC | 4.2M | 3.6% |
| GOLDMAN SACHS GROUP INC | 3.5M | 3.0% |
| WASATCH ADVISORS LP | 3.5M | 3.0% |
| TWO SIGMA INVESTMENTS, LP | 3.5M | 2.9% |
| Soleus Capital Management, L.P. | 3.4M | 2.9% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 3.0M | 2.6% |
| BANK OF AMERICA CORP /DE/ | 2.7M | 2.3% |
| GEODE CAPITAL MANAGEMENT, LLC | 2.5M | 2.1% |
| Ikarian Capital, LLC | 2.4M | 2.1% |
| STATE STREET CORP | 2.1M | 1.8% |
| ACADIAN ASSET MANAGEMENT LLC | 1.8M | 1.5% |
| Candriam S.C.A. | 1.8M | 1.5% |
| D. E. Shaw & Co., Inc. | 1.7M | 1.5% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.7M | 1.5% |
| Patient Square Capital LP | 1.6M | 1.4% |
| HighVista Strategies LLC | 1.3M | 1.1% |
| RENAISSANCE TECHNOLOGIES LLC | 1.2M | 1.0% |
Largest changes
| Manager | Action | Previous | Current | Change |
|---|---|---|---|---|
| BlackRock, Inc. | Increased | 2.0M | 7.9M | +5.8M |
| Squadron Capital Management LLC | Increased | 2.3M | 7.2M | +5.0M |
| Ikarian Capital, LLC | New | 0 | 2.4M | +2.4M |
| Candriam S.C.A. | New | 0 | 1.8M | +1.8M |
| STATE STREET CORP | Increased | 383.0K | 2.1M | +1.7M |
| CITADEL ADVISORS LLC | Increased | 2.5M | 4.2M | +1.7M |
| Patient Square Capital LP | New | 0 | 1.6M | +1.6M |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 951.0K | 2.5M | +1.6M |
| JPMORGAN CHASE & CO | Increased | 3.2M | 4.7M | +1.5M |
| HighVista Strategies LLC | New | 0 | 1.3M | +1.3M |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 2.5M | 1.2M | -1.3M |
| MILLENNIUM MANAGEMENT LLC | Reduced | 1.4M | 215.4K | -1.2M |
| GOLDMAN SACHS GROUP INC | Increased | 2.4M | 3.5M | +1.1M |
| SILVERARC CAPITAL MANAGEMENT, LLC | Increased | 1.9M | 3.0M | +1.1M |
| NORTHERN TRUST CORP | Increased | 189.5K | 1.2M | +971.1K |
| JANE STREET GROUP, LLC | Reduced | 1.2M | 302.8K | -944.1K |
| ORBIMED ADVISORS LLC | Sold Out | 856.4K | 0 | -856.4K |
| DIMENSIONAL FUND ADVISORS LP | Increased | 442.5K | 1.2M | +746.0K |
| BOOTHBAY FUND MANAGEMENT, LLC | New | 0 | 736.3K | +736.3K |
| D. E. Shaw & Co., Inc. | Increased | 1.1M | 1.7M | +680.7K |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New | 0 | 680.1K | +680.1K |
| FMR LLC | Increased | 272.4K | 894.1K | +621.7K |
| UBS Group AG | Increased | 215.9K | 829.0K | +613.1K |
| Velan Capital Investment Management LP | New | 0 | 570.0K | +570.0K |
| WASATCH ADVISORS LP | Increased | 3.0M | 3.5M | +560.9K |
13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.